Management of diabetes from preconception to the postnatal period: summary of NICE guidance

doi:10.1136/bmj.39505.641273.AD

BMJ 2008;336:714-717 (29 March), doi:10.1136/bmj.39505.641273.AD

Practice

Guidelines

Management of diabetes from preconception to the postnatal period: summary of NICE guidance

The Guideline Development Group

Moira A Mugglestone, National Collaborating Centre for Women’s and Children’s Health, London W1T 2QA mmugglestone@ncc-wch.org.uk

The first 150 words of the full text of this article appear below.

Diabetes in pregnancy is associated with risks to the woman(for example, higher rates of miscarriage, pre-eclampsia, andpreterm labour) and to the developing fetus and baby (for example,higher rates of congenital malformations, macrosomia, birthinjury, and perinatal mortality).¹ ² This article summarisesthe most recent guidance from the National Institute for Healthand Clinical Excellence (NICE) on how to manage diabetes andits complications from preconception to the postnatal period.³

NICE recommendations are based on systematic reviews of bestavailable evidence. When minimal evidence is available, recommendationsare based on the guideline development group’s opinionof what constitutes good practice. Evidence levels for the recommendationsare given in italic in square brackets.

From adolescence onwards, advise women about the importanceof avoiding unplanned pregnancy. [Based on a high quality nationalclinical audit]
Inform women and their families about howdiabetes affects pregnancyand how pregnancy affects diabetes. . . [Full text of this article]

Information and advice for women with diabetesand their families should cover the following points
For womenwith pre-existing diabetes information and advice should alsocover the following points

CiteULike

Complore

Connotea

Del.icio.us Add to Digg

Digg

Technorati What's this?

Relevant Articles

Commentary: Controversies in management of diabetes from preconception to the postnatal period: Lucy C Chappell and Sarah J Germain
BMJ 2008 336: 717-718. [Extract] [Full Text] [PDF]

Screen all pregnant women for risk factors for gestational diabetes, says NICE: Zosia Kmietowicz
BMJ 2008 336: 689. [Extract] [Full Text]

Outcomes of pregnancy in insulin dependent diabetic women: results of a five year population cohort study: I F Casson, C A Clarke, C V Howard, O McKendrick, S Pennycook, P O D Pharoah, M J Platt, M Stanisstreet, D van Velszen, and S Walkinshaw
BMJ 1997 315: 275-278. [Abstract] [Full Text]

Prospective population based survey of outcome of pregnancy in diabetic women: results of the Northern Diabetic Pregnancy Audit, 1994: Gillian Hawthorne, S Robson, E A Ryall, D Sen, S H Roberts, and M P Ward Platt
BMJ 1997 315: 279-281. [Abstract] [Full Text]

This article has been cited by other articles:

Jensen, D. M., Korsholm, L., Ovesen, P., Beck-Nielsen, H., Moelsted-Pedersen, L., Westergaard, J. G., Moeller, M., Damm, P. (2009). Peri-Conceptional A1C and Risk of Serious Adverse Pregnancy Outcome in 933 Women With Type 1 Diabetes. Diabetes Care 32: 1046-1048 [Abstract] [Full text]
Simmons, D., Devers, M. C., Wolmarans, L., Johnson, E. (2009). Difficulties in the Use of Risk Factors to Screen for Gestational Diabetes Mellitus. Diabetes Care 32: e8-e8 [Full text]
Kolagasi, O., Sari, F., Akar, M., Sari, R. (2009). Normal Pregnancy and Healthy Child After Continued Exposure to Gliclazide and Ramipril During Pregnancy. The Annals of Pharmacotherapy 43: 147-149 [Abstract] [Full text]